NO993911L - Remedier/Forebygningsmidler for Õndedrettssykdommer - Google Patents

Remedier/Forebygningsmidler for Õndedrettssykdommer

Info

Publication number
NO993911L
NO993911L NO993911A NO993911A NO993911L NO 993911 L NO993911 L NO 993911L NO 993911 A NO993911 A NO 993911A NO 993911 A NO993911 A NO 993911A NO 993911 L NO993911 L NO 993911L
Authority
NO
Norway
Prior art keywords
group
respiratory diseases
remedies
prevention
substituted
Prior art date
Application number
NO993911A
Other languages
English (en)
Other versions
NO993911D0 (no
Inventor
Takayuki Namiki
Masayuki Yuasa
Takako Takakuwa
Satoshi Ichinomiya
Masashi Tamai
Naoki Hiyama
Yukio Kawazu
Tomoaki Yahiro
Mayumi Sugio
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Publication of NO993911L publication Critical patent/NO993911L/no
Publication of NO993911D0 publication Critical patent/NO993911D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen angår et terapeutisk og preventivt medikament for ånde-drettssykdommer, omfattende, som en aktiv bestanddel, en forbindelse repre-sentert ved den generelle formel (1):. hvor Rrepresenterer en lineær, forgrenet eller cyklisk alkylgruppe som har 1 til 10 karbonatomer; og R2 representerer et hydrogen- eller halogenatom, en substituert alkylgruppe, en aminogruppe som kan være substituert, en karboksyl-gruppe, en alkoksykarbonylgruppe, en karbamoylgruppe eller en alkylkarbamoyl-gruppe eller et salt derav. Denne forbindelsen har utmerket trakeobronkodilativ effekt og hemmende effekt på luftveis-konstriksjon.
NO993911A 1997-02-14 1999-08-13 Remedier/Forebygningsmidler for åndedrettssykdommer NO993911D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4721197 1997-02-14
JP4719797 1997-02-14
PCT/JP1997/004878 WO1998035968A1 (fr) 1997-02-14 1997-12-26 Produits therapeutiques/prophylactiques des maladies respiratoires

Publications (2)

Publication Number Publication Date
NO993911L true NO993911L (no) 1999-08-13
NO993911D0 NO993911D0 (no) 1999-08-13

Family

ID=26387351

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993911A NO993911D0 (no) 1997-02-14 1999-08-13 Remedier/Forebygningsmidler for åndedrettssykdommer

Country Status (8)

Country Link
EP (1) EP0976754B1 (no)
JP (1) JP4192250B2 (no)
AT (1) ATE271051T1 (no)
AU (1) AU727572B2 (no)
CA (1) CA2279641A1 (no)
DE (1) DE69729890T2 (no)
NO (1) NO993911D0 (no)
WO (1) WO1998035968A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004075846A2 (en) 2003-02-25 2004-09-10 Bristol-Myers Squibb Company Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
WO2005087775A1 (ja) * 2004-03-15 2005-09-22 Ono Pharmaceutical Co., Ltd. 三環式複素環化合物およびその化合物を有効成分として含有する医薬組成物
RU2015143517A (ru) * 2013-03-13 2017-04-19 Дженентек, Инк. Пиразолсодержащие соединения и их применения
EA032081B1 (ru) * 2014-12-08 2019-04-30 Янссен Сайенсиз Айрлэнд Юси ЗАМЕЩЕННЫЕ ПИПЕРИДИНОМ ПРОИЗВОДНЫЕ ПИРАЗОЛО[1,5-a]ПИРИМИДИНА С ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ РЕПЛИКАЦИИ РЕСПИРАТОРНО-СИНЦИТИАЛЬНОГО ВИРУСА (RSV)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0688999B2 (ja) * 1988-10-13 1994-11-09 ポーラ化成工業株式会社 ピロロ〔３，２―ｅ〕ピラゾロ〔１，５―ａ〕ピリミジン誘導体およびこれを含有する医薬
JPH07242670A (ja) * 1994-03-08 1995-09-19 Pola Chem Ind Inc ピロロ［３，２−ｅ］ピラゾロ［１，５−ａ］ピリミジン誘導体及びこれを含有する循環器系疾患治療剤
JPH07267960A (ja) * 1994-03-28 1995-10-17 Lederle Japan Ltd ピロロ［３，２−ｅピラゾロ［１，５−ａピリミジン誘導体及びこれを含有する循環器系疾患治療剤
JPH10218881A (ja) * 1997-02-03 1998-08-18 Pola Chem Ind Inc 新規なピロロピラゾロピリミジン誘導体

Also Published As

Publication number Publication date
ATE271051T1 (de) 2004-07-15
EP0976754A4 (en) 2001-01-10
AU8705198A (en) 1998-09-08
AU727572B2 (en) 2000-12-14
NO993911D0 (no) 1999-08-13
JP4192250B2 (ja) 2008-12-10
CA2279641A1 (en) 1998-08-20
EP0976754B1 (en) 2004-07-14
WO1998035968A1 (fr) 1998-08-20
DE69729890D1 (de) 2004-08-19
DE69729890T2 (de) 2005-07-14
EP0976754A1 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
NO20020968L (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
FI950309A (fi) Proliiniamidijohdannaisia
PT976748E (pt) Derivados de pirrolidina com actividade inibidora de fosfolipase a2
EP1092435A4 (en) ANTIDIABETIC DRUGS
HK1076816A1 (no)
IL169184A0 (en) Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
GR3025568T3 (en) Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia.
ES2134313T3 (es) Utilizacion de derivados de pregnano para el tratamiento de tumores.
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
NO993911L (no) Remedier/Forebygningsmidler for Õndedrettssykdommer
MY122570A (en) Benzamide derivatives and drugs containing the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application